Nathan Fountain

Nathan Fountain

Director/Board Member at ACUMEN PHARMACEUTICALS, INC.

Net worth: 128 561 $ as of 2026-06-29

63 year
Consumer Services
Commercial Services
Health Technology

Profile

Nathan B. Fountain is President & Chief Executive Officer at Hexokine Therapeutics, Inc. since 2021.
Dr. Fountain serves as Chairman-Research Roundtable for Epilepsy at the Epilepsy Foundation.
Dr. Fountain is an Independent Director at Acumen Pharmaceuticals, Inc. since 2021.
Dr. Fountain is Director-FE Dreifuss Comprehensive Epilepsy at the University of Virginia since 1998.
Dr. Fountain is a Professor at The University of Virginia School of Medicine.
Former roles include Director at Marmot Mountain, LLC (New York) and President & Director at the National Association of Epilepsy Centers.
Education includes undergraduate studies at the University of Iowa and a doctorate from the University of Iowa Carver College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-08 48,150 ( 0.07% ) 128 561 $ 2026-06-29

Nathan Fountain active positions

CompaniesPositionStart
ACUMEN PHARMACEUTICALS, INC. Director/Board Member 2021-05-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Hexokine Therapeutics, Inc.
Chief Executive Officer 2021-10-31
Corporate Officer/Principal 1997-12-31

Former positions of Nathan Fountain

CompaniesPositionEnd
Director/Board Member -
President -
See the detail of Nathan Fountain's experience

Training of Nathan Fountain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Commercial Services

Retail Trade

Consumer Services

Consumer Services

Commercial Services

Hexokine Therapeutics, Inc.

  1. Stock Market
  2. Insiders
  3. Nathan Fountain